Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxiety.
J Neurol Neurosurg Psychiatry
; 90(3): 353-360, 2019 03.
Article
in En
| MEDLINE
| ID: mdl-30630956
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Anxiety Disorders
/
Botulinum Toxins, Type A
/
Depressive Disorder
/
Migraine Disorders
/
Neuromuscular Agents
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Qualitative_research
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
J Neurol Neurosurg Psychiatry
Year:
2019
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom